This coverage index provides an overview of Kenya’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
93%
Blinding trachoma
46%
Intestinal worms
28%
Bilharzia
20%
River blindness
N/A
4.65 million
people received treatment in Kenya in 2019
3.678 million
people did not receive treatment in Kenya in 2019
Elephantiasis
Treatment coverage increased from 87% in 2018 to 93% in 2019.
People needing treatment
4.10m
People receiving treatment
3.81m
Blinding trachoma
Treatment coverage increased from 1% in 2018 to 46% in 2019.
People needing treatment
3.22m
People receiving treatment
1.49m
Intestinal worms
Treatment coverage increased from 23% in 2018 to 28% in 2019.
Pre-sch and school-aged children needing treatment
5.94m
Pre-school and school-aged children receiving treatment
1.68m
Bilharzia
Treatment coverage increased from 0% in 2018 to 20% in 2019.
School-aged children needing treatment
1.92m
School-aged children receiving treatment
383k
River blindness
Kenya does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Kenya.